Supplementary Figure S1. from High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target
Authors:
- Takuma YoshimuraTYTakuma Yoshimura
- Takashi KamataniTKTakashi Kamatani
- Aki OokuboAOAki Ookubo
- Mio TakahashiMTMio Takahashi
- Manabu ItohMIManabu Itoh
- Toshiki EbisudaniTEToshiki Ebisudani
- Yohei MasugiYMYohei Masugi
- Tomomi ToyonagaTTTomomi Toyonaga
- Junko HamamotoJHJunko Hamamoto
- Keiko SaotomeKSKeiko Saotome
- Kensuke SakaiKSKensuke Sakai
- Tomoko YoshihamaTYTomoko Yoshihama
Open Access
- 25 July 2025
- other
- Published by American Association for Cancer Research (AACR)